[HTML][HTML] Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa

JA Feinstein, AL Bruckner, B Chastek… - Orphanet Journal of …, 2022 - Springer
Background Dystrophic epidermolysis bullosa (DEB) is a serious, ultra-rare, genetic
blistering disease that requires a multidisciplinary care team and lifelong, proactive disease …

[HTML][HTML] Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

A Hwang, A Kwon, CH Miller… - Orphanet journal of rare …, 2024 - Springer
Background Invasive cutaneous squamous cell carcinomas (cSCC) are a leading cause of
death in recessive dystrophic epidermolysis bullosa (RDEB), a rare blistering …

Overview of familial syndromes with increased skin malignancies

HY Juan, AE Zhou, KM Hoegler… - Archives of …, 2023 - Springer
The vast majority of skin cancers can be classified into two main types: melanoma and
keratinocyte carcinomas. The most common keratinocyte carcinomas include basal cell …

Surgical management of hand deformities in patients with recessive dystrophic epidermolysis bullosa

X Zhou, Y Zhang, M Zhao, Y Jian, J Huang… - Journal of plastic …, 2020 - Taylor & Francis
Recessive dystrophic epidermolysis bullosa (RDEB) is a congenital disease caused by a
mutation in the COL7A1 gene and frequently results in hand contractures and …

[HTML][HTML] Эпидемиология и состояние оказания медицинской помощи больным врожденным буллезным эпидермолизом в Российской Федерации

АА Кубанов, АЭ Карамова, ВВ Чикин… - Вестник Российской …, 2018 - cyberleninka.ru
Обоснование. Врожденный буллезный эпидермолиз (ВБЭ) является наследственным
заболеванием. Качество и продолжительность жизни больных наиболее тяжелыми …

Combined anti‐inflammatory and low‐dose antiproliferative therapy for squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.

A Reimer, S Lu, Y He… - Journal of the …, 2020 - search.ebscohost.com
Cutaneous squamous cell carcinoma (SCC) is the most severe, life-limiting complication of
recessive dystrophic epidermolysis bullosa (RDEB).[1] In RDEB, collagen VII deficiency …

Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference …

B Castelo, D Viñal, R Maseda, L Ostios… - Clinical and …, 2019 - Springer
Background Cutaneous squamous cell carcinoma (cSCC) is the leading cause of death in
patients with recessive dystrophic epidermolysis bullosa (RDEB). We provide the …

Overlap in oncogenic and pro-inflammatory pathways associated with Areca nut and nicotine exposure

K Garg, A Kumar, V Kizhakkethil, P Kumar… - Cancer Pathogenesis …, 2023 - mednexus.org
Background: Betel nut/areca nut/Areca catechu is one of the most commonly used
psychoactive substance, and is also a major preventable cause of cancer. Unlike other …

Morphological and morphometric analysis of cutaneous squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa: A retrospective study

A Filoni, G Cicco, L Lospalluti… - Journal of the …, 2020 - Wiley Online Library
Background Recessive dystrophic epidermolysis bullosa is a highly disabling
genodermatosis characterized by skin and mucosal fragility and blistering. Cutaneous …

[HTML][HTML] Advances for pediatricians in 2022: allergy, anesthesiology, cardiology, dermatology, endocrinology, gastroenterology, genetics, global health, infectious …

C Caffarelli, F Santamaria, E Piro, S Basilicata… - Italian journal of …, 2023 - Springer
The last year saw intensive efforts to advance knowledge in pediatric medicine. This review
highlights important publications that have been issued in the Italian Journal of Pediatrics in …